QB0208-1

N/A

Report date: 2025/02/25 16:56:31
NME

Base Information

Drug NameQB0208-1
Drug Alias NameQB0208-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypercholesterolemiaDiabetic FootProstatic Hyperplasia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesBeijing Qingbo Huineng Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Qingbo Huineng Pharmaceutical Technology Co LtdBeijing Tide Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaDiabetic FootProstatic Hyperplasia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A